Evelina Rubinchik, PhD

Chief Scientific Officer

Dr. Evelina Rubinchik has over 25 years of leadership experience in the biopharmaceutical industry. She has previously served as Senior Director of Product  Development at BioWest Therapeutics, Director of Nonclinical Development at MIGENIX Inc., and most recently as a nonclinical development consultant for Canadian and U.S.-based biopharmaceutical companies. Dr. Rubinchik has been responsible for the development of successful nonclinical  strategies for multiple drug candidates. The scope of her experience spans from lead candidate identification, IND (Investigational New Drug) status through to NDA (New Drug Application).